NEW YORK: U.S. healthcare investors have found success this year buying stocks of companies whose products improve eyesight, treat pets and fix crooked teeth, all viewed as unlikely to fall victim to political and regulatory issues pressuring a wide swath of the sector.
Shares of many health insurers, pharmaceutical and biotechnology companies, and pharmacy services companies have lagged. Earnings for S&P 500 healthcare companies are expected to rise by 6.2per cent in 2019, according to IBES data from Refinitiv, more than twice the 2.7per cent earnings growth expected for the S&P 500 overall, despite the market's strong performance this year.Two of the three top-performing S&P 500 healthcare stocks so far in 2019 are in the dental space. Shares of Dentsply Sirona Inc and Align Technology Inc have jumped 53per cent and 49per cent, respectively in 2019.
"No one is really talking about reforming dental and how dental is provided," Kreger said."The idea is you can get the growth potential without the regulatory uncertainty or the political uncertainty."
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: BusinessTimes - 🏆 15. / 51 Read more »